Pixantrone confers radiosensitization in KRAS mutated cancer cells by suppression of radiation-induced prosurvival pathways
Author:
Publisher
Elsevier BV
Subject
Physiology (medical),Biochemistry
Reference48 articles.
1. Biological response of cancer cells to radiation treatment;Baskar;Front. Mol. Biosci.,2014
2. Development and characterisation of acquired radioresistant breast cancer cell lines;Gray;Radiat. Oncol.,2019
3. Development of novel radiosensitizers through the national cancer institute’s small business innovation research program;Zakeri;Radiat. Res.,2020
4. Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways;Morgan;Clin. Cancer Res.,2015
5. Drugging the undruggable: advances on RAS targeting in cancer;Molina-Arcas;Genes,2021
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pixantrone as a novel MCM2 inhibitor for ovarian cancer treatment;European Journal of Pharmacology;2024-09
2. Phase-separated super-enhancers confer an innate radioresistance on genomic DNA;Journal of Radiation Research;2024-06-14
3. Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for hepatocellular carcinoma;Hepatology;2023-10-11
4. PI3K/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer;Cell Death & Disease;2023-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3